These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36083979)

  • 1. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; D'Anna L; Russo M; Steinacker P; Kuhle J; Tumani H; Blennow K; Otto M
    Brain; 2023 Feb; 146(2):421-437. PubMed ID: 36083979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neurofilament light chain studies in neurological disorders, hints for interpretation.
    Mariotto S; Sechi E; Ferrari S
    J Neurol Sci; 2020 Sep; 416():116986. PubMed ID: 32563076
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurofilaments as biomarkers in neurological disorders - towards clinical application.
    Khalil M; Teunissen CE; Lehmann S; Otto M; Piehl F; Ziemssen T; Bittner S; Sormani MP; Gattringer T; Abu-Rumeileh S; Thebault S; Abdelhak A; Green A; Benkert P; Kappos L; Comabella M; Tumani H; Freedman MS; Petzold A; Blennow K; Zetterberg H; Leppert D; Kuhle J
    Nat Rev Neurol; 2024 May; 20(5):269-287. PubMed ID: 38609644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels.
    Kušnierová P; Zeman D; Hradílek P; Čábal M; Zapletalová O
    J Clin Lab Anal; 2019 Sep; 33(7):e22948. PubMed ID: 31199010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease.
    Peters N
    Mol Diagn Ther; 2022 Jan; 26(1):1-6. PubMed ID: 34825310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
    Verde F; Milone I; Bulgarelli I; Peverelli S; Colombrita C; Maranzano A; Calcagno N; Ticozzi N; Perego GB; Parati G; Torresani E; Ratti A; Silani V
    J Neurol; 2022 Nov; 269(11):5691-5701. PubMed ID: 35781535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
    Oosterveld LP; Verberk IMW; Majbour NK; El-Agnaf OM; Weinstein HC; Berendse HW; Teunissen CE; van de Berg WDJ
    Mov Disord; 2020 Feb; 35(2):288-295. PubMed ID: 31737952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
    Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
    Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.
    Heckler I; Venkataraman I
    J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light chain as neuronal injury marker - what is needed to facilitate implementation in clinical laboratory practice?
    Arslan B; Zetterberg H
    Clin Chem Lab Med; 2023 Jun; 61(7):1140-1149. PubMed ID: 36880940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light in MS: The first true blood-based biomarker?
    Thebault S; Bose G; Booth R; Freedman MS
    Mult Scler; 2022 Sep; 28(10):1491-1497. PubMed ID: 33565908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies.
    Yuan A; Nixon RA
    Front Neurosci; 2021; 15():689938. PubMed ID: 34646114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light levels predict clinical progression and death in multiple system atrophy.
    Chelban V; Nikram E; Perez-Soriano A; Wilke C; Foubert-Samier A; Vijiaratnam N; Guo T; Jabbari E; Olufodun S; Gonzalez M; Senkevich K; Laurens B; Péran P; Rascol O; Le Traon AP; Todd EG; Costantini AA; Alikhwan S; Tariq A; Ng BL; Muñoz E; Painous C; Compta Y; Junque C; Segura B; Zhelcheska K; Wellington H; Schöls L; Jaunmuktane Z; Kobylecki C; Church A; Hu MTM; Rowe JB; Leigh PN; Massey L; Burn DJ; Pavese N; Foltynie T; Pchelina S; Wood N; Heslegrave AJ; Zetterberg H; Bocchetta M; Rohrer JD; Marti MJ; Synofzik M; Morris HR; Meissner WG; Houlden H
    Brain; 2022 Dec; 145(12):4398-4408. PubMed ID: 35903017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neurofilament light chain as outcome marker for intensive care unit patients.
    Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS
    J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy.
    Beerepoot S; Heijst H; Roos B; Wamelink MMC; Boelens JJ; Lindemans CA; van Hasselt PM; Jacobs EH; van der Knaap MS; Teunissen CE; Wolf NI
    Brain; 2022 Mar; 145(1):105-118. PubMed ID: 34398223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of neurofilament light chain in COVID‑19: A potential prognostic biomarker.
    Heidari A; Rezaei N
    Acta Neurobiol Exp (Wars); 2023; 83(2):111-126. PubMed ID: 37493529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological symptoms and blood neurofilament light levels.
    Barro C; Zetterberg H
    Acta Neurol Scand; 2021 Jul; 144(1):13-20. PubMed ID: 33734429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).
    Nicoletti TF; Rossi S; Vita MG; Perna A; Guerrera G; Lino F; Iacovelli C; Di Natale D; Modoni A; Battistini L; Silvestri G
    J Neurol; 2022 Sep; 269(9):5085-5092. PubMed ID: 35575811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke.
    Zhang X; Wang H; Li L; Deng X; Bo L
    Front Aging Neurosci; 2022; 14():921809. PubMed ID: 35875791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.